Comparison of CAT-21A/T Gene Polymorphism in Women with Preeclampsia and Control Group

Document Type : Original Article

Authors

1 Preventive Gynecology Research Center; Department of OB and GYN, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Clinical Biochemistry, Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

3 Department of OB and GYN, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Preeclampsia (PE) is one of the main causes of maternal and perinatal mortality and morbidity. Evidence shows that oxidative stress plays an important role in the pathophysiology of the PE. As catalase is a key enzyme in antioxidant enzymatic defense which protects cell from oxidative damage, in this study, we aimed to investigate the relationship between CAT-21A/T (rs7943316) polymorphism and PE susceptibility. Materials and Methods: This case–control study was conducted on 155 PE women and 159 normotensive pregnant women. Polymerase chain reaction-restriction fragment length polymorphism method was used for genotyping. Results: There was no association between CAT-21AT and TT genotypes and PE susceptibility. However, the CAT-21A/T polymorphism was associated with 1.6-fold higher risk of PE in dominant model (AA vs. AT + TT) (odds ratio [OR] 1.6 [95% confidence interval [CI]: 0.9–2.9]; P = 0.04). However, the CAT-21A/T polymorphism was not associated with PE in recessive model (TT vs. AA + AT) (OR 1.3 [95% CI: 0.8–2.1]; P = 0.4). Conclusions: The CAT-21A/T polymorphism could be a risk factor for PE susceptibility in dominant model.

Keywords

1.
American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.  Back to cited text no. 1
    
2.
Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL. Williams Obstetrics. 24th ed. New York: McGraw Hill; 2014. p. 102-5.  Back to cited text no. 2
    
3.
Betteridge DJ. What is oxidative stress? Metabolism 2000;49:3-8.  Back to cited text no. 3
    
4.
Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: A review. Reprod Biol Endocrinol 2012;10:49.  Back to cited text no. 4
    
5.
Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci 2004;61:192-208.  Back to cited text no. 5
    
6.
Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options. Curr Neuropharmacol. 2009;7(1):65-74.  Back to cited text no. 6
    
7.
Quan F, Korneluk RG, Tropak MB, Gravel RA. Isolation and characterization of the human catalase gene. Nucleic Acids Res. 1986;14:5321-335.  Back to cited text no. 7
    
8.
Saify K, Saadat I, Saadat M. Influence of A-21T and C-262T genetic polymorphisms at the promoter region of the catalase (CAT) on gene expression. Environ Health Prev Med 2016;21:382-6.  Back to cited text no. 8
    
9.
Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y, et al. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 2001;109:95-8.  Back to cited text no. 9
    
10.
Mansego ML, Solar Gde M, Alonso MP, Martínez F, Sáez GT, Escudero JC, et al. Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens 2011;29:492-500.  Back to cited text no. 10
    
11.
Watanabe Y, Metoki H, Ohkubo T, Katsuya T, Tabara Y, Kikuya M, et al. Accumulation of common polymorphisms is associated with development of hypertension: A 12-year follow-up from the Ohasama study. Hypertens Res 2010;33:129-34.  Back to cited text no. 11
    
12.
Kim TH, Hong JM, Oh B, Cho YS, Lee JY, Kim HL, et al. Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population. Osteoarthritis Cartilage 2008;16:1060-6.  Back to cited text no. 12
    
13.
Hernández-Guerrero C, Hernández-Chávez P, Romo-Palafox I, Blanco-Melo G, Parra-Carriedo A, Pérez-Lizaur A, et al. Genetic polymorphisms in SOD (rs2070424, rs7880) and CAT (rs7943316, rs1001179) enzymes are associated with increased body fat percentage and visceral fat in an obese population from central Mexico. Arch Med Res 2016;47:331-9.  Back to cited text no. 13
    
14.
Vialykh EK, Solidolova MA, Bushueva OIu, Bulgakova IV, Polonikov AV. Catalase gene polymorphism is associated with increased risk of cerebral stroke in hypertensive patients. Zh Nevrol Psikhiatr Im S S Korsakova 2012;112:3-7.  Back to cited text no. 14
    
15.
Kouremenos N, Zacharopoulou IV, Triantafyllidi H, Zacharopoulos GV, Mornos C, Filippatos G, et al. Genes and genetic variations involved in the development of hypertension: Focusing on a Greek patient cohort. Hellenic J Cardiol 2014;55:9-16.  Back to cited text no. 15
    
16.
Kolusari A, Kurdoglu M, Yildizhan R, Adali E, Edirne T, Cebi A, et al. Catalase activity, serum trace element and heavy metal concentrations, and Vitamin A, D and E levels in pre-eclampsia. J Int Med Res 2008;36:1335-41.  Back to cited text no. 16
    
17.
Mistry HD, Gill CA, Kurlak LO, Seed PT, Hesketh JE, Méplan C, et al. Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks' gestation in nulliparous women who subsequently develop preeclampsia. Free Radic Biol Med 2015;78:147-55.  Back to cited text no. 17